Unlock Funding: Bristol Myers Squibb Competitive Research Grants

Scope

Bristol Myers Squibb (BMS) is committed to advancing science through its Competitive Research Grants program. This initiative supports Independent Research (ISR) designed and conducted by external investigators. While BMS accepts applications across various therapeutic areas—including Oncology, Hematology, Immunology, Fibrosis, and Neuroscience—they periodically release specific Requests for Proposals (RFPs) for targeted needs.

Currently, a specific funding cycle is approaching for Cardiovascular Research, with a focus on Mavacamten. Researchers should propose studies examining impact on morbidity, quality of life, and clinical outcomes.

Eligibility

This opportunity is open to independent investigators, including:

Qualified medical doctors and researchers.

Faculty at academic and medical institutions.

Researchers at tax-exempt 501(c)(3) organizations or global equivalents.

Applicants must be able to assume the responsibilities of a sponsor, including the management of the study’s design, execution, and data analysis.

Partnership Details

Successful applicants may receive financial support and/or provision of BMS proprietary investigational products. The grant is designed to foster independent scientific inquiry that aligns with BMS’s strategic medical and scientific objectives. The process typically begins with a concept submission, followed by a full protocol invitation if selected.

Deadlines
Upcoming Cycle for Cardiovascular (Mavacamten):
Opens: February 6, 2026
Closes: February 19, 2026

Researchers are encouraged to prepare their concepts early, as submission windows can be brief.